These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37523025)

  • 41. Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.
    Langlois F; Lim DST; Yedinak CG; Cetas I; McCartney S; Cetas J; Dogan A; Fleseriu M
    Pituitary; 2018 Feb; 21(1):32-40. PubMed ID: 29032459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pituitary carcinoma: a review of the literature.
    Ragel BT; Couldwell WT
    Neurosurg Focus; 2004 Apr; 16(4):E7. PubMed ID: 15191336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report.
    Andrioli M; Pecori Giraldi F; Losa M; Terreni M; Invitti C; Cavagnini F
    Endocr J; 2010; 57(9):833-7. PubMed ID: 20595779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment and long-term outcomes in pituitary carcinoma: a cohort study.
    Santos-Pinheiro F; Penas-Prado M; Kamiya-Matsuoka C; Waguespack SG; Mahajan A; Brown PD; Shah KB; Fuller GN; McCutcheon IE
    Eur J Endocrinol; 2019 Oct; 181(4):397-407. PubMed ID: 31349217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma?
    Lee EJ; Ahn JY; Noh T; Kim SH; Kim TS; Kim SH
    Neurosurgery; 2009 Mar; 64(3 Suppl):ons62-9; discussion ons69-70. PubMed ID: 19240574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Invasion of the corticotrophs.
    Mayberg MR
    J Neurosurg; 2012 Feb; 116(2):269-71; discussion 270-1. PubMed ID: 21923245
    [No Abstract]   [Full Text] [Related]  

  • 47. Refractory corticotroph adenomas.
    Sumal AKS; Zhang D; Heaney AP
    Pituitary; 2023 Jun; 26(3):269-272. PubMed ID: 36917358
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Giant pituitary adenoma: histological types, clinical features and therapeutic approaches.
    Iglesias P; Rodríguez Berrocal V; Díez JJ
    Endocrine; 2018 Sep; 61(3):407-421. PubMed ID: 29909598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gamma Knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy.
    Mauermann WJ; Sheehan JP; Chernavvsky DR; Laws ER; Steiner L; Vance ML
    J Neurosurg; 2007 Jun; 106(6):988-93. PubMed ID: 17564169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metastasis to pituitary adenoma: case report and review of the literature.
    Hoellig A; Niehusmann P; Flacke S; Kristof RA
    Cent Eur Neurosurg; 2009 Aug; 70(3):149-53. PubMed ID: 19701874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ectopic invasive ACTH-secreting pituitary adenoma mimicking chordoma: a case report and literature review.
    Li Y; Zhu JG; Li QQ; Zhu XJ; Tian JH
    BMC Neurol; 2023 Feb; 23(1):81. PubMed ID: 36814261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery.
    Dickerman RD; Oldfield EH
    J Neurosurg; 2002 Dec; 97(6):1343-9. PubMed ID: 12507132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ENDOCRINE TUMOURS: Thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases.
    De Herdt C; Philipse E; De Block C
    Eur J Endocrinol; 2021 Jul; 185(2):R65-R74. PubMed ID: 34132199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-Term Survival After Transformation of an Adrenocorticotropic Hormone-Secreting Pituitary Macroadenoma to a Silent Corticotroph Pituitary Carcinoma.
    Rotman LE; Vaughan TB; Hackney JR; Riley KO
    World Neurosurg; 2019 Feb; 122():417-423. PubMed ID: 30447452
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The coexistence of infundibular pituicytoma and Cushing's disease due to pituitary adenoma: A case report.
    Gezer E; Selek A; Cetinarslan B; Canturk Z; Tarkun I; Ceylan S
    Endocr Regul; 2019 Oct; 53(4):263-267. PubMed ID: 31734654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
    Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
    Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.